Compare LTGO & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | LTGO | IAUX |
|---|---|---|
| Founded | N/A | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2026 | 2021 |
| Metric | LTGO | IAUX |
|---|---|---|
| Price | $21.97 | $1.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.50 |
| AVG Volume (30 Days) | 292.6K | ★ 12.1M |
| Earning Date | N/A | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.76 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $95,193,000.00 |
| Revenue This Year | N/A | $132.25 |
| Revenue Next Year | N/A | $89.76 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 89.12 |
| 52 Week Low | $17.22 | $0.79 |
| 52 Week High | $25.93 | $2.24 |
| Indicator | LTGO | IAUX |
|---|---|---|
| Relative Strength Index (RSI) | 61.32 | 55.27 |
| Support Level | $18.46 | $1.42 |
| Resistance Level | $25.47 | $1.95 |
| Average True Range (ATR) | 1.87 | 0.08 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 46.72 | 52.05 |
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.